Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides

Inositol Not Working? Seven Reasons, and What to Check First

9 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

Most inositol trials need 12 to 24 weeks before cycles or hormones shift, so “not working” after a few weeks often just means not enough time yet. Beyond timing, the seven usual causes are: the wrong ratio, a phenotype that responds less, an unaddressed thyroid or iron problem, a low-quality product, the wrong endpoint, or genuine non-response.

“Inositol isn’t working” almost always means one of seven specific, checkable things, not a verdict on the compound itself. Before assuming the mechanism has failed you, work through timing, ratio, phenotype, thyroid and iron status, product quality, the endpoint you’re tracking, and — only after the other six are ruled out — genuine non-response. This page assumes you already know the basics of what inositol is and the standard dose; if you don’t, start there first. Each reason below has a concrete way to check it, because “give it more time” without a plan is how three months turns into a year with no answer.

How long does inositol actually take to regulate periods?

Twelve weeks is the earliest point a controlled trial has picked up a cycle-level change from myo-inositol, and the strongest hormonal shifts take roughly twice that long. In a 12-week trial of 20 overweight women with PCOS, menstrual cyclicity returned in every previously amenorrhoeic or oligomenorrhoeic participant taking 2g of myo-inositol daily, versus no change on folic acid alone — a small trial, but the earliest cycle-level result on record. A meta-analysis of nine randomised trials found that the rise in SHBG, one marker of improving androgen balance, only showed up in the trials that ran myo-inositol for at least 24 weeks, not in the shorter ones.

That gap between 12 and 24 weeks is not a formality. If you are six weeks in, you have not run the experiment long enough to call it a failure. If you are past 24 weeks with no change at all, that is the point where the other six reasons below become the more likely explanation.

Reason 1: You haven’t given it enough time

Most people who report inositol “not working” tried it for four to eight weeks, which is shorter than every trial window in the previous section. What to check: the date you actually started, not the date you decided to look into it — memory rounds up. What to do: commit to a 12-week minimum and a 24-week full assessment before changing course, and use ovulation predictor kits or basal body temperature rather than bleeding alone, since a withdrawal bleed can occur without ovulation.

Reason 2: Your ratio or dose is off

A 3-month trial of 56 women with PCOS tested seven different myo-inositol to D-chiro-inositol ratios side by side and found the 40:1 ratio restored ovulation more effectively than any other combination tested, including plain D-chiro-inositol alone. Push the ratio toward more D-chiro-inositol and the benefit drops rather than rises — the same trial found effectiveness fell as the formula shifted away from 40:1 toward DCI. What to check: the label. If it lists a “proprietary inositol blend” with no stated ratio, or leads with D-chiro-inositol first, you may not be taking what the trials tested. The full ratio explanation is covered separately if you want the mechanism.

More is not simply better here, either. Mouse studies found that D-chiro-inositol at human-equivalent doses of 1,200mg/day or higher produced ovarian tissue changes and shifted testosterone in the wrong direction — a finding in animals, not confirmed in humans, but a real reason not to assume stacking extra D-chiro-inositol on top of a 40:1 product will help. What to do: check your total daily D-chiro-inositol across every product you take, including multivitamins, and keep myo-inositol as the dominant component.

Reason 3: Your phenotype doesn’t respond as strongly

A 2023 retrospective study split women with PCOS into hyperandrogenic phenotypes (A, B and C) and a non-hyperandrogenic phenotype (D), then tracked six months of myo-inositol in both groups. Metabolic and hormonal parameters improved significantly in the hyperandrogenic group, while the improvement in the non-hyperandrogenic group was negligible. If your PCOS presents without elevated androgens, this is a real reason the same dose can do less for you than it did for someone in a forum thread with a different phenotype. What to check: whether your labs actually show raised testosterone or free androgen index, or whether your diagnosis rests on irregular cycles and ovarian appearance alone.

Reason 4: An unaddressed thyroid or iron problem

Close to one in five women with PCOS has subclinical hypothyroidism that hasn’t been named as such — a 2025 meta-analysis of 29 studies and 5,765 women found a pooled prevalence of 19.7%, and thyroid dysfunction independently worsens the same insulin-resistance markers inositol is meant to improve. Iron deficiency behaves similarly: low ferritin drives fatigue and can disrupt ovulation through mechanisms that have nothing to do with the insulin pathway inositol acts on. Neither problem responds to inositol, because inositol was never built to fix either one. What to check: ask for TSH and ferritin alongside whatever panel you last had done for PCOS — most initial work-ups don’t include both by default.

Reason 5: The product itself is the problem

Inositol supplements are not standardised the way a prescription drug is, and formulation quality varies across brands selling the same “myo-inositol” label. What to check: whether the product states a specific myo-to-D-chiro ratio (ideally 40:1), lists a milligram dose rather than a vague blend size, and carries third-party testing for identity and purity. A product that hides its ratio behind “proprietary blend” wording gives you no way to know whether you’re actually replicating what the trials above used. What to do: switch to a product that discloses both numbers before concluding the compound itself has failed you. Powder formats measured by scoop rather than a sealed sachet are the most common place a real dose ends up lower than the label implies, since scoop volume varies with how tightly the powder is packed.

Reason 6: You’re tracking the wrong endpoint

Every inositol trial above measured ovulation, cycle regularity, insulin markers, or androgen levels — not weight, not acne clearing on its own, not energy. If you started inositol hoping to see the scale move and judged it a failure when it didn’t, you were tracking an outcome the compound was never shown to reach. What to check: which of the actually-studied endpoints applies to your reason for taking it, and whether you’re measuring that one specifically — a period tracker and a basic metabolic panel, not the bathroom scale.

Reason 7: You may be a genuine non-responder

Even in the best-run trials, not everyone improves. The 2017 meta-analysis found real average effects across nine trials, but averages describe groups, not guarantees for one person — a meaningful minority of participants across these trials showed no measurable change in insulin or androgen markers despite adequate dose and duration. After genuinely ruling out reasons 1 through 6, some people simply do not respond to this mechanism. What to do: that is the point to discuss switching mechanisms entirely with a prescriber, rather than escalating the inositol dose further.

Who this will not help, even at the correct dose and ratio

Inositol will not fix a thyroid problem, will not correct an iron deficiency, and has not been shown to move the scale on its own. If your PCOS is the non-hyperandrogenic phenotype, expect a smaller effect than the hyperandrogenic phenotypes see in the trials above. And if you need ovulation induced on a timeline — trying to conceive this cycle, not eventually — inositol’s slower, more modest track record is a real reason a prescriber may reach for a different tool first; the head-to-head against metformin sets out how those tracks actually compare, and the comparison against berberine covers a third mechanism entirely if insulin-pathway supplements in general haven’t moved your numbers.

Table 1 — the seven reasons inositol appears not to be working, and what to check for each.
ReasonWhat it looks likeWhat to check or do
Not enough timeStarted fewer than 12 weeks agoReassess at 12 weeks, then again at 24
Wrong ratio or doseLabel has no stated ratio, or leads with D-chiro-inositolConfirm a 40:1 myo:D-chiro ratio and ≥2g myo-inositol daily
Phenotype mismatchNon-hyperandrogenic phenotype (normal testosterone, irregular cycles only)Confirm your labs actually show raised androgens
Unaddressed thyroid or ironFatigue, cycles still irregular despite adherenceAsk for TSH and ferritin alongside your PCOS panel
Product qualityVague “inositol blend,” no third-party testingSwitch to a product disclosing ratio and milligram dose
Wrong endpointExpecting weight loss or acne clearing specificallyTrack ovulation, cycle length and insulin markers instead
Genuine non-responseNo change after 24 weeks at correct dose and ratioDiscuss a different mechanism with your prescriber

You may see PCOS increasingly written as polyendocrine metabolic ovarian syndrome (PMOS), after a May 2026 global consensus renamed the condition. Nothing about how inositol works, or how long it takes, changed with the name.

Common questions

  • How long does inositol take to regulate periods?

    Twelve weeks is the earliest a trial has detected a cycle-level change; the strongest reproductive and hormonal effects, including a rise in SHBG, generally need 24 weeks of consistent use before they show up.
  • Why is my inositol not working after 3 months?

    Check the ratio first — trials found 40:1 myo-to-D-chiro-inositol outperformed every other tested combination. Then check your phenotype, thyroid and ferritin, and confirm you're tracking ovulation rather than weight or skin.
  • Does inositol work for lean PCOS?

    Inositol's mechanism runs through insulin resistance, which is usually less pronounced in lean PCOS. It can still help, but the phenotype-specific data shows a smaller average effect than in the insulin-resistant, hyperandrogenic phenotypes.
  • Can taking too much D-chiro-inositol make inositol less effective?

    Animal data suggests it can. Mouse studies found that higher D-chiro-inositol doses produced ovarian changes and worked against reproductive outcomes, which is why the 40:1 myo-to-D-chiro ratio outperforms formulas with more D-chiro-inositol.
  • Should I switch to metformin if inositol isn't working?

    That is a genuine option worth raising with a prescriber, especially if you've ruled out timing, ratio, phenotype and thyroid or iron issues. The two work through different mechanisms, and one not working doesn't predict the other will fail too.

Your next step

Before changing anything, write down three things: the exact date you started, the ratio and daily milligram dose on your product’s label, and your most recent TSH and ferritin results if you have them. Those three numbers turn “it’s not working” into a specific, checkable question — and they are exactly what reasons 1, 2 and 4 above ask you to confirm first. If inositol genuinely isn’t the right mechanism for you, the rest of the supplements and medications section covers the other options on the table.

More on this

Sources

  1. 1.Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017.
  2. 2.Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019.
  3. 3.Bevilacqua A, Dragotto J, Lucarelli M, Di Emidio G, Monastra G, Tatone C. High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries. Int J Mol Sci. 2021.
  4. 4.Unfer V, Russo M, Aragona C, Bilotta G, Montanino Oliva M, Bizzarri M. Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes. Biomedicines. 2023.
  5. 5.Shekarian A, Mazaheri-Tehrani S, Shekarian S, et al. Prevalence of subclinical hypothyroidism in polycystic ovary syndrome and its impact on insulin resistance: a systematic review and meta-analysis. BMC Endocr Disord. 2025.
  6. 6.Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008.
  7. 7.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.